Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Vaccine. 2013 Aug 12;31(42):4795–4801. doi: 10.1016/j.vaccine.2013.07.085

Table 1.

Serum titers of the immunized Ifnarko-CD46Ge mice against human lambda immunoglobulin chain in antigen-mediated ELISA. The titers were measured on day 32 (for the 6–8-old mice) or 4 weeks post immunization (for the other two experiments).

Experiment Immunization Anti-lambda titer Difference (in fold)
6–8-Week old mice (day 32) MV-lambda-NAP 1:6400–1:102,400a (1:36,480)b 19.78c (p = 0.013)
MV-lambda 1:200–1:6400 (1:1844)
10–12-Week old mice (4 weeks) MV-lambda-NAP 1:1600–1:25,600 (10,720) 9.08 (p = 0.010)
MV-lambda 1:100–1:1600 (1:1180)
16-Week old mice (4 weeks) MV-lambda-NAP 1:6400–1:25,600 (1:16,000) 6.21 (p < 0.001)
MV-lambda 1:800–1:6400 (1:2578)
a

ELISA titer range.

b

Mean antibody titer.

b

Difference in titers MV-lambda-NAP vs. MV-lambda immunized groups in fold with the p value.